| Literature DB >> 35740792 |
Viktoria Karl1, Konstantin Johannes Scholz1, Karl-Anton Hiller1, Isabelle Tabenski2, Frederike Schenke2, Wolfgang Buchalla1, Christian Kirschneck3, Katrin Bekes4, Fabian Cieplik1.
Abstract
The need for dental rehabilitations under general anesthesia (DRGAs) is continuously increasing, particularly for dental treatment of children. The present retrospective cohort study aimed to investigate potential risk factors for repeated need of DRGA in a cohort of patients from a private pediatric dental practice. Demographic and anamnestic data, dental status, and treatments performed during DRGA were retrospectively analyzed from the electronic dental charts of 1155 children that received at least one DRGA between October 2016 and December 2021. The median age of all children was 5 years at time of their first DRGA. The rate of repeated DRGAs was 9%. Patients with repeated need of DRGA were significantly younger at time of their first DRGA and revealed significantly more often a history of preterm birth and current use of a baby bottle as compared to patients with only one DRGA. There were significantly fewer treatments (regardless of type) in the second DRGA than at the first. Within the limitations of this study, young age at first DRGA, a history of preterm birth, and current use of a baby bottle may be risk factors for repeated need of DRGA. The search for effective strategies to minimize the repeated need for DRGA in children remains critical.Entities:
Keywords: children; general anesthesia; pediatric dentistry; risk factors
Year: 2022 PMID: 35740792 PMCID: PMC9221647 DOI: 10.3390/children9060855
Source DB: PubMed Journal: Children (Basel) ISSN: 2227-9067
Demographic and anamnestic data of all included patients at the time of their first DRGA.
| Time of 1st DRGA | Significant Differences * | |||
|---|---|---|---|---|
|
|
|
| 1 DRGA | |
| 1155 (100%) | 1051 (91%) | 104 (9%) | ||
| 5 (3.7; 6.7) | 5.1 (3.8; 6.8) | 4.2 (3.1; 5.7) | <0.001 a | |
| female | 46.7 | 46.8 | 45.2 | – b |
| male | 53.3 | 53.2 | 54.8 | |
| ASA I | 86.6 | 86.7 | 85.6 | – b |
| ASA II | 11.3 | 11.2 | 12.5 | |
| ASA III | 2.1 | 2.1 | 1.9 | |
| yes | 13.5 | 13.4 | 14.4 | – b |
| no | 85.0 | 85.2 | 83.7 | |
| yes | 3.8 | 3.6 | 4.9 | – b |
| no | 94.5 | 94.7 | 93.3 | |
| yes | 7.9 | 7.7 | 9.6 | – b |
| no | 90.5 | 90.7 | 88.5 | |
| lack of compliance | 52.2 | 52.2 | 52.1 | – b |
| age in relation to clinical treatment need | 47.2 | 47.2 | 46.9 | |
| known general diseases or conditions | 0.6 | 0.6 | 1 | |
| statutory health insurance | 97.6 | 97.6 | 97.1 | – b |
| private health insurance | 1.6 | 1.6 | 1.9 | |
| social welfare | 0.8 | 0.8 | 1.0 | |
| academic | 8.2 | 8.2 | 8.7 | – b |
| job that requires training | 47.6 | 47.7 | 47.1 | |
| seeking work, unskilled workers | 23.9 | 23.8 | 25 | |
| not classifiable | 20.3 | 20.4 | 19.2 | |
| 5.4 | 4.9 | 10.6 | 0.013 b | |
| 87.7 | 88 | 84.6 | – b | |
| 22.7 | 22.5 | 25 | – b | |
| 5.7 | 5.6 | 7.7 | – b | |
| yes | 14.5 | 14.2 | 18.3 | – b |
| no | 85.5 | 85.8 | 81.7 | |
| toothpaste | 46.4 | 46 | 52 | – b |
| gel | 3.8 | 3.6 | 4.8 | |
| salt | 12.3 | 12.5 | 10.6 | |
| tablet | 3.3 | 3.2 | 3.9 | |
| no fluoridation measures | 32.4 | 32.5 | 30.8 | |
| unknown | 15.1 | 15.4 | 11.5 | |
| 2 | 2.2 | 1 | – b | |
| 16.1 | 14.7 | 30.8 | <0.001 b | |
Depiction of medians (1st quartile; 3rd quartile) or relative proportions. * Statistically significant differences were calculated from pairwise comparisons between patients that received 1 DRGA or ≥2 DRGAs (a Mann–Whitney U or b χ2-tests, respectively; α = 0.05). p-value, significant (p ≤ 0.05); –, not significant (p > 0.05). # Percentages do not add up to 100% due to missing data in <2% of the patients. § Multiple answers per patient were possible.
Dental status of all included patients at their respective DRGAs.
| 1st DRGA | 2nd DRGA | Significant Differences * | ||||
|---|---|---|---|---|---|---|
|
|
|
|
| 1 DRGA vs. | 1st vs. 2nd DRGA | |
| 1155 (100%) | 1051 (91%) | 104 (9%) | 104 (9%) | |||
| 5 (3.7; 6.7) | 5.1 (3.8; 6.8) | 4.2 (3.1; 5.7) | 5.8 (4.5; 7.3) | <0.001 a | n.d. | |
|
| 8 (5; 10) | 8 (5; 10) | 8 (5; 10) | 11 (7.5; 14) | – a | <0.001 a |
| d | 8 (5; 10) | 8 (5; 10) | 7 (5; 10) | 4 (1.5; 5.5) | ||
| m | 0 (0; 0) | 0 (0; 0) | 0 (0; 0) | 0 (0; 0.5) | ||
| f | 0 (0; 0) | 0 (0; 0) | 0 (0; 0) | 6 (3; 9) | ||
|
| 9 (6; 11) | 9 (6; 11) | 9 (6; 11) | 11 (8; 14) | – a | <0.001 a |
| d | 7 (4; 9) | 7 (3.3; 9) | 8 (6; 9.5) | 3 (2; 5) | ||
| m | 0 (0; 0) | 0 (0; 0) | 0 (0; 0) | 0 (0; 0) | ||
| f | 0 (0; 2) | 0 (0; 2) | 0 (0; 1) | 7 (3; 8) | ||
| D | 0 (0; 2) | 0 (0; 2) | 0 (0; 0.5) | 0 (0; 0) | ||
| M | 0 (0; 0) | 0 (0; 0) | 0 (0; 0) | 0 (0; 0) | ||
| F | 0 (0; 0) | 0 (0; 0) | 0 (0; 0) | 0 (0; 0) | ||
|
| 4.5 (2; 12.8) | 4.5 (2; 12.8) | n.d. | n.d. | ||
| D | 4.5 (2; 10) | 4.5 (2; 10) | ||||
| M | 0 (0; 0) | 0 (0; 0) | ||||
| F | 0 (0; 2.5) | 0 (0; 2.5) | ||||
| no ECC | 40.3 | 41.2 | 31.7 | § | – b | n.d. |
| type I | 22.8 | 22.9 | 21.2 | |||
| type II | 29.6 | 28.6 | 39.4 | |||
| type III | 7.3 | 7.2 | 7.7 | |||
Depiction of medians (1st quartile; 3rd quartile) or relative proportions. * Statistically significant differences were calculated from pairwise comparisons between patients that received 1 DRGA or ≥2 DRGAs or between data for the 1st and 2nd DRGA for the patients who received ≥2 DRGAs (a Mann–Whitney U or b χ2-tests, respectively). p-value, significant (p ≤ 0.05); –, not significant (p > 0.05); n.d., not determined. § ECC classification was only recorded at the first DRGA.
Performed treatments in all patients during their DRGAs as well as attendance of post-operative recall.
| 1st DRGA | 2nd DRGA | Significant Differences * | ||||
|---|---|---|---|---|---|---|
|
|
|
|
| 1 DRGA vs. | 1st vs. 2nd DRGA | |
| 1155 (100%) | 1051 (91%) | 104 (9%) | 104 (9%) | |||
|
| 0 (0; 3) | 0 (0; 4) | 0 (0; 2) | 0 (0; 0) | – a | 0.007 a |
| no | 57.5 | 57.4 | 58.7 | 76 | ||
| 1–2 | 15.8 | 14.7 | 26 | 16.3 | ||
| 3–4 | 19.1 | 20 | 10.6 | 7.7 | ||
| ≥5 | 7.6 | 7.9 | 4.8 | - | ||
|
| 7 (4; 10) | 7 (5; 10) | 7 (4; 10) | 3 (0; 6) | – a | <0.001 a |
| no | 9.9 | 9.6 | 12.5 | 28.8 | ||
| 1–6 | 39 | 39.9 | 30.8 | 51 | ||
| 7–12 | 39.3 | 39.2 | 40.4 | 19.2 | ||
| 13–18 | 10.1 | 9.9 | 12.5 | 1 | ||
| ≥19 | 1.6 | 1.4 | 3.8 | - | ||
|
| 1 (0; 3) | 1 (0; 3) | 2 (0; 3) | 0 (0; 2) | – a | 0.003 a |
| no | 37.7 | 38.1 | 33.7 | 56.7 | ||
| 1–2 | 32.6 | 33 | 28.8 | 26 | ||
| 3–4 | 19 | 18.1 | 27.9 | 9.6 | ||
| 5–6 | 7.3 | 7.6 | 3.8 | 4.8 | ||
| ≥7 | 3.5 | 3.2 | 5.8 | 2.9 | ||
|
| 1 (0; 2) | 1 (0; 2) | 1 (0; 2) | 0 (0; 1) | – a | <0.001 a |
| no | 43.7 | 44.1 | 40.4 | 71.2 | ||
| 1–2 | 37.1 | 36.9 | 39.4 | 21.2 | ||
| 3–4 | 14.8 | 14.7 | 16.3 | 6.7 | ||
| ≥5 | 4.3 | 4.4 | 3.8 | 1 | ||
|
| 0 (0; 0) | 0 (0; 0) | 0 (0; 0) | 0 (0; 0) | <0.001 a | <0.001 a |
| no | 91 | 92.1 | 79.8 | 100 | ||
| 1 | 4.9 | 4.7 | 7.7 | - | ||
| 2 | 2.3 | 1.8 | 7.7 | - | ||
| ≥3 | 1.7 | 1.4 | 4.8 | - | ||
|
| 1 (0; 3) | 1 (0; 3) | 1 (0; 2) | 1 (0; 3) | (0.051) a | – a |
| no | 37.1 | 36.3 | 45.2 | 30.8 | ||
| 1–3 | 42.6 | 43 | 38.5 | 57.7 | ||
| 4–6 | 14.5 | 14.6 | 13.5 | 10.6 | ||
| ≥7 | 5.9 | 6.2 | 2.9 | 1 | ||
| attendance within four weeks after DRGA | 82.2 | 82.5 | 78.8 | 73.1 | – b | – b |
| no preventive recall appointment | 42.7 | 43.3 | 36.5 | 26.9 | 0.026 b | 0.001 b |
| ≤2 within first post-operative year | 27.5 | 26.3 | 40.4 | 36.5 | ||
| >2 within first post-operative year | 12.5 | 12 | 17.3 | 7.7 | ||
| first post-operative year not expired | 17.3 | 18.5 | 5.8 | 25.0 | ||
Depiction of medians (1st quartile; 3rd quartile) or relative proportions. * Statistically significant differences were calculated from pairwise comparisons between patients that received 1 DRGA or ≥2 DRGAs or between data for the 1st and 2nd DRGA for the patients who received ≥2 DRGAs (a Mann–Whitney U or b χ2-tests, respectively). p-value, significant (p ≤ 0.05); –, not significant (p > 0.05).